세계의 의약품 시장 - 규모, 점유율, 성장 분석 : 분자별, 제품별, 유형별, 질환별, 투여법별, 처방별, 연령별, 최종 용도별, 지역별 산업 예측(2024-2031년)

Global Pharmaceuticals Market size was valued at USD 209.85 billion in 2022 and is poised to grow from USD 222.44 billion in 2023 to USD 354.54 billion by 2031, growing at a CAGR of 6.0% during the forecast period (2024-2031).

Pharmaceuticals, defined as drug-containing products formulated for medical purposes, are witnessing a surge in demand, driven by increasing consumer awareness about health and wellness. This trend accelerated during the COVID-19 pandemic, where pharmaceutical companies responsible for vaccine development not only survived but thrived amidst economic instability, highlighting the sector's resilience. As individuals prioritize their health, the pharmaceutical market is poised for continued growth. The ongoing commitment to healthcare solutions underscores the essential role of pharmaceuticals in society, ensuring sustained market expansion as long as public health needs persist. With a focus on innovation and accessibility, the industry is well-positioned to meet the evolving demands of consumers in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceuticals Market Segmental Analysis

Global Pharmaceuticals Market is segmented by molecule, product, type, disease, administration, formulation, age, end use and region. Based on molecule, the market is segmented into biologics & biosimilars (large molecules) and conventional drugs (small molecules). Based on product, the market is segmented into branded and generic. Based on type, the market is segmented into prescription and OTC. Based on disease, the market is segmented into cardiovascular diseases, cancer, diabetes, infectious diseases, neurological disorders, respiratory diseases, autoimmune diseases, mental health disorders, gastrointestinal disorders, women's health diseases, genetic and rare genetic diseases, dermatological conditions, obesity, renal diseases, liver conditions, hematological disorders, eye conditions, infertility conditions, endocrine disorders, allergies and others. Based on administration, the market is segmented into oral, topical, parenteral, inhalations and other. Based on formulation, the market is segmented into tablets, capsules, injectable, sprays, suspensions, powders and other formulations. Based on age, the market is segmented into children & adolescents, adults and geriatric. Based on end use, the market is segmented into hospitals, clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceuticals Market

One of the key drivers of the Global Pharmaceuticals market is the rising aging population. Recent data from the Bureau of Census highlights a growth in the demographic of individuals aged 65 and older, increasing from 8% in 2015 to 9% in 2021. This demographic shift results from improved living standards and an expanding global population, significantly altering the population structure in many nations. The United Nations projects a staggering 56% rise in individuals aged 60 and above from 2015 to 2030. As people live longer, age-related health issues are becoming more prevalent, putting enormous pressure on healthcare systems worldwide. This scenario creates a critical need for innovative pharmaceutical solutions, as advancements in nanotechnology and artificial intelligence offer promising avenues to develop new treatments. Consequently, the growing patient base directly fuels the demand for medical interventions, driving substantial growth in the pharmaceuticals market.

Restraints in the Global Pharmaceuticals Market

The global pharmaceuticals market faces significant restraints stemming from a shortage of skilled labor and the volatility of raw material costs. The development of new drugs necessitates specialized skill sets that are currently available only in select research organizations, leading to an inadequate workforce. Additionally, fluctuating raw material prices hinder market expansion, creating further challenges for pharmaceutical companies. Compounding these issues is a pronounced talent gap, as the skills possessed by the current workforce do not adequately align with the advanced requirements of biopharma production. Companies struggle to find expertise in critical areas like automation, computer science, and process modeling, hindering innovation and progress within the industry.

Market Trends of the Global Pharmaceuticals Market

The Global Pharmaceuticals market is experiencing a significant trend toward restructuring and recovery post-COVID-19, as companies adapt to the new normal. As the demand for innovative therapies surges, firms are pivoting their business models to enhance resilience against future disruptions. The pandemic catalyzed a shift to digital health solutions and telemedicine, prompting pharmaceutical companies to invest in technology and streamline operations. There is also an increased focus on supply chain diversification and sustainability practices. This evolving landscape presents opportunities for growth and collaboration, positioning the pharmaceutical sector for a robust rebound and long-term evolution in healthcare delivery and access.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Pharmaceuticals Market Size by Molecule & CAGR (2024-2031)

• Market Overview
• Biologics & Biosimilars (Large Molecules)
• Conventional Drugs (Small Molecules)

Global Pharmaceuticals Market Size by Product & CAGR (2024-2031)

• Market Overview
• Branded
• Generic

Global Pharmaceuticals Market Size by Type & CAGR (2024-2031)

• Market Overview
• Prescription
• OTC

Global Pharmaceuticals Market Size by Disease & CAGR (2024-2031)

• Market Overview
• Cardiovascular Diseases
• Cancer
• Diabetes
• Infectious Diseases
• Neurological Disorders
• Respiratory Diseases
• Autoimmune Diseases
• Mental Health Disorders
• Gastrointestinal Disorders
• Women'S Health Diseases
• Genetic and Rare Genetic Diseases
• Dermatological Conditions
• Obesity
• Renal Diseases
• Liver Conditions
• Hematological Disorders
• Eye Conditions
• Infertility Conditions
• Endocrine Disorders
• Allergies
• Others

Global Pharmaceuticals Market Size by Administration & CAGR (2024-2031)

• Market Overview
• Oral
• Topical
• Parenteral
  • Intravenous
  • Intramuscular
• Inhalations
• Other

Global Pharmaceuticals Market Size by Formulation & CAGR (2024-2031)

• Market Overview
• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Other Formulations

Global Pharmaceuticals Market Size by Age & CAGR (2024-2031)

• Market Overview
• Children & Adolescents
• Adults
• Geriatric

Global Pharmaceuticals Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals
• Clinics
• Others

Global Pharmaceuticals Market Size & CAGR (2024-2031)

• North America (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
  • USA
  • Canada
• Europe (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Molecule, Product, Type, Disease, Administration, Formulation, Age, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertex Pharmaceuticals Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alexion Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations